• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Alizé Pharma - Articles and news items

Alizé-Pharma-II

Jazz Pharmaceuticals acquires 100% of the shares of Alizé Pharma II

Industry news / 11 May 2016 / Victoria White, Digital Content Producer

A subsidiary of Jazz Pharmaceuticals has acquired 100% of the shares of Alizé Pharma II in a deal valued at up to €18 million…

Prader-Willi Syndrome

AZP-531 and its potential in Prader-Willi Syndrome

Blog, Z Homepage promo / 9 May 2016 / Victoria White, Digital Content Producer

In this exclusive interview, Thierry Abribat, president of Alizé Pharma, discusses AZP-531 and its potential as a treatment for Prader-Willi Syndrome…

Prader-Willi-Syndrome

Promising top-line results for AZP-531 in Prader-Willi Syndrome

Industry news / 26 April 2016 / Victoria White, Digital Content Producer

Alizé Pharma has announced top-line results of a Phase II clinical trial of AZP-531 in patients with Prader-Willi Syndrome (PWS)…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +